Scientists dive into bone marrow to unlock vaccine memory secrets

NCT ID NCT07493460

First seen Apr 30, 2026 · Last updated Jun 22, 2026 · Updated 7 times

Summary

This study looks at how the immune system 'remembers' vaccines by tracking special cells in the bone marrow. Twenty-five healthy adults will receive four different vaccines at once and give blood, bone marrow, and lymph node samples over two years. The goal is to understand why some vaccine protection lasts longer than others.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Washington University School of Medicine Infectious Disease Clinical Research Unit

    St Louis, Missouri, 63110, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

trivalent inactivated influenza vaccine (TIV), nonavalent HPV vaccine, hepatitis A vaccine, tetanus/diphtheria/pertussis vaccine (Tdap)

What this could lead to

If successful, this could help scientists design better vaccines that provide longer-lasting protection.

What could go wrong

This is a small, early-phase observational study with only 25 healthy adults, so results may not apply to everyone. The bone marrow and lymph node procedures are invasive and carry minor risks like pain or infection.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.